Geraldine Pannu
CIK: 0001817209
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jul 26, 2026PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
33.5K shares- - May 21, 2026RBB
RBB Bancorp
Exercise(M)Direct700 shares- - May 21, 2026RBB
RBB Bancorp
Exercise(M)Direct1.8K shares- - May 21, 2026RBB
RBB Bancorp
Award(A)DirectRestricted Stock Units
2.5K shares- - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
Purchase(P)Direct2.1K shares at avg. $2.54$5K - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
100K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectStock Options (Right to Buy)
300K shares- - Jul 24, 2025PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock
175.3K shares- - May 21, 2025RBB
RBB Bancorp
Exercise(M)Direct2.8K shares- - May 15, 2025RBB
RBB Bancorp
Exercise(M)Direct700 shares- - Sep 3, 2024PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock
31.2K shares- - Sep 3, 2024PCSA
Processa Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock
31.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 26, 2026 |  PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 33,500 | - | - | Direct |
| May 21, 2026 |  RBB RBB Bancorp | Exercise(M) | 700 | - | $0 | Direct |
| May 21, 2026 | RBB RBB Bancorp | Exercise(M) | 1,846 | - | $0 | Direct |
| May 21, 2026 | RBB RBB Bancorp | Award(A) Restricted Stock Units | 2,546 | - | - | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase(P) | 2,072 | $2.54 | $5,253 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 100,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Stock Options (Right to Buy) | 300,000 | - | - | Direct |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock | 175,299 | - | - | Direct |
| May 21, 2025 | RBB RBB Bancorp | Exercise(M) | 2,821 | - | - | Direct |
| May 15, 2025 | RBB RBB Bancorp | Exercise(M) | 700 | - | - | Direct |
| Sep 3, 2024 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock | 31,206 | - | - | Direct |
| Sep 3, 2024 | PCSA Processa Pharmaceuticals, Inc. | Award(A) Restricted Stock | 31,206 | - | - | Direct |
1-12 of 12 transactions
About Pannu Geraldine
Pannu Geraldine (SEC CIK 0001817209) files insider reports with the SEC as Director of Processa Pharmaceuticals, Inc. (PCSA) and Director of RBB Bancorp (RBB).
Signal8 holds 9 ownership filings by Pannu Geraldine, all Form 4s, filed between Sep 18, 2024 and Jul 28, 2026. Those filings report 12 transactions, from Sep 3, 2024 to Jul 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pannu Geraldine's filings is in VERO BEACH, FL.
Recent filings by Pannu Geraldine
- Jul 26, 2026: Grant or award of PCSA derivative securities (Form 4, code A).
- May 21, 2026: Option exercises of RBB shares (2 lines, Form 4, code M).
- May 21, 2026: Grant or award of RBB derivative securities (Form 4, code A).
- Mar 31, 2026: Open-market purchase of PCSA shares (Form 4, code P).
- Oct 1, 2025: Grants or awards of PCSA derivative securities (2 lines, Form 4, code A).
Other insiders filing for Processa Pharmaceuticals, Inc. (PCSA)
- Ng George K, Chief Executive Officer
- GUJRATHI SHEILA, Director
- Yorke Justin W, Director
- SKIBSTED RUSSELL, Chief Financial Officer
- Neal James R, Director
- Lin Patrick, Chief Business - Strategy Off